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and Langman, 1990; Schwartz, 1992). The most promi-
nent costimulatory molecule is CD28, but other mole-
cules such as lymphocyte function-associated antigen
1 (LFA-1), intercellular adhesion molecule 1 (I-CAM), or
41BB-L have also been suggested to be important for
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T cell activation (Springer et al., 1987; Seventer et al.,Departments of Medical Biophysics and
1990; Goodwin et al., 1993; Lenschow et al., 1996; De-Immunology
Benedette et al., 1997). It is, however, not clear to what610 University Avenue
extent the different molecules exhibit overlapping func-Toronto, Ontario, M5G 2M9
tions and how exactly they facilitate or costimulate TCanada
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CD28 is a disulphide linked homodimeric glycoprotein620 University Avenue
which is expressed on murine T cells and up-regulatedToronto, Ontario, M5G 2C1
after T cell activation. CD28 interacts with B7-1 and B7-2Canada
on antigen-presenting cells (APCs) (Lenschow et al.,
1996). T cell responses are greatly impaired in the ab-
sence of the B7-CD28 interaction and, under some cir-Summary
cumstances, T cell anergy rather than T cell activation
is induced (Schwartz, 1990; Harding et al., 1992; LinsleyEfficient T cell activation requires the engagement of
and Ledbetter, 1993; KuÈ ndig et al., 1996; Lenschow eta variety of ligand/receptor molecules in addition to T
al., 1996). Moreover, blocking of B7 interactions hascell receptor (TCR)±major histocompatibility complex
been shown to inhibit autoimmunity and graft rejection(MHC)/peptide interactions. The leukocyte function
in vivo (Lenschow et al., 1992; Linsley et al., 1992; Turkaantigen 1 (LFA-1) and the CD28 glycoprotein have both
et al., 1992; Lin et al., 1993; Finck et al., 1994). Neverthe-been implicated in T cell activation. The present study
less, high affinity ligands could activate T cells in thedissects the roles of LFA-1 and CD28 in the activation
absence of CD28 (Shahinian et al., 1993; Lucas et al.,of naive virus-specific CD81 T cells. We demonstrate
1995; Bachmann et al., 1996; KuÈ ndig et al., 1996).that LFA-1 facilitates T cell activation by lowering the
LFA-1 (CD11a/CD18) is a cell adhesion molecule be-amounts of antigen necessary for T cell activation.
longing to the integrin family. It is expressed on T andIn the absence of LFA-1, 100-fold more antigen was
B cells, granulocytes, and macrophages (Springer et al.,required for T cell±antigen-presenting cell (APC) conju-
1987). The natural ligands for LFA-1 are ICAM-1, 2, andgation and all subsequent events of T cell activation,
3, which are expressed on most leukocytes (Springer,including TCR down-regulation, Ca21-flux, T cell prolifer-
1990). LFA-1 and ICAM-1 have been shown to play anation, and lytic effector cell induction. Thus, LFA-1
important role in lymphocyte recirculation and inflam-facilitates the functional triggeringof TCRs bypromoting
mation (Sligh et al., 1993; Springer, 1994; Schmits et al.,adhesion of T cells to APCs but does not affect T cell
1996) as a well as in T cell activation. In particular, LFA-1activation otherwise. In contrast, CD28 played an en-
has been found to enhance the contact between T cellstirely different role during T cell activation. CD28 re-
and APCs and facilitate cytotoxic T lymphocyte (CTL)±
duced the number of TCRs that had to be triggered
target cell interactions (Davignon et al., 1981). Interest-
for T cell activation and allowed activation of T cells
ingly, stimulation of T cells by receptor cross-linking or
by low affinity ligands. CD28 but not LFA-1 prevented phorbol esters transiently increases the affinity of LFA-1
induction of T cell unresponsiveness after stimulation for ICAM-1 (Dustin and Springer, 1989; Lollo et al., 1993;
of TCRs. These results demonstrate that LFA-1 and Buckley et al., 1997), which subsequently leads to an
CD28 exhibit distinct, nonoverlapping ways to influ-
up-regulated expression of LFA-1 (Springer et al., 1987).
ence T cell activation and suggest that the terms Therefore, it is likely that LFA-1 is important to establish
costimulation and signal 2 should be revisited. the initial T cell±APC contact and after an activation step
to strengthen the contact between T cells and APCs. In
Introduction addition, LFA-1 has also been suggested to act as a
costimulatory molecule for T cell activation (Springer et
T cell activation is a complex, multistep process involv- al., 1987; Seventer et al., 1990; Sligh et al., 1993; Schmits
ing a multitude of molecules. For full T cell activation, et al., 1996; Cai et al., 1996, 1997).
two signals are necessary: an antigen-specific signal 1, Costimulation is an important parameter for self/non-
mediated by the interaction of T cell receptors (TCRs) self discrimination by lymphocytes. The two-signal the-
with major histocompatibility complex (MHC)/peptide ory of lymphocyte activation proposes that lymphocytes
complexes, and a second signal delivered by costimula- receiving a TCR-mediated signal 1 in the absence of an
tory molecules (Lafferty and Woolnough, 1977; Cohn additional, accessory molecule-mediated signal 2 are
functionally tolerized (Lafferty and Woolnough, 1977;
Cohn and Langman, 1990; Schwartz, 1990). Thus, signal²Present address: Basel Institute for Immunology, Grenzacher-
2 is important not only for full T cell activation but alsostrasse 486, 4005 Basel, Switzerland.
³To whom correspondence should be addressed. to prevent the induction of unresponsiveness. However,
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these two aspects of signal 2 are not usually distin- the dose response curve was shifted by about 100-fold.
Proliferation of TCR3LFA2/2 T cells was, however,guished. This is most likely because they are technically
difficult to separate, since TCR-mediated and accessory similar to controls at high peptide concentrations. Simi-
lar findings were observed for the induction of cytolyticmolecule-mediated signals are integrated intracellularly
and are difficult to analyze independently. Thus, it would effector cells (Figure 1B).
When the peptide A4Y, a weak ligand for the trans-be desirable to have assay systems that distinguish be-
tween the following three types of stimuli: triggering of genic TCR, was used for stimulation, LFA-1±deficient
T cells again required approximately 100 times moreTCR (signal 1), costimulation of T cell activation (signal
2c, c for costimulation), and tolerance induction (signal peptide for similar levels of T cell proliferation (Figure
1C). This response is clearly different from CD28-defi-2t, t for tolerance).
Several assays were used to assess these three types cient T cells, which failed to proliferate upon stimulation
with peptide A4Y even at high peptide concentrationsof stimuli. The number of TCRs functionally triggered by
MHC/peptide complexes at a given time is a quantitative (Figure 1C) (Bachmann et al., 1996).
Since LFA-1 is expressed both on T cells and APCs,assessment of the amount of signal 1 received by a cell.
It has been shown that functionally triggered TCRs are the experiments were repeated with peritoneal macro-
phages from LFA-1±deficient mice. Absence of LFA-1rapidly internalized, and reduced TCR levels can be
measured by FCM (Valitutti et al., 1995b). The number on APCs had only a minor effect on T cell proliferation
(data not shown). Thus, expression of LFA-1 on T cellsof internalized TCRs was found to correlate strictly with
the efficiency of T cell activation (Viola and Lanzavec- was more critical for T cell activation than LFA-1 expres-
sion on APCs.chia, 1996; Bachmann et al., 1997a). Thus, TCR down-
regulation reflects the number of triggered TCRs and These results show that the absence of LFA-1 and
CD28 have significantly different effects on T cell activa-therefore is an appropriate way to measure signal 1. In
addition, the correlation of signal 1 with T cell activation tion. CD28 alters the range of peptides to which a given
T cell can respond, while LFA-1 changes the minimalin the presence or absence of different accessory mole-
cules can distinguish between molecules that facilitate number of ligands required to induce T cell proliferation.
generation of signal 1 and true costimulatory molecules
that deliver signal 2c. Induction of T cell anergy in the LCM Virus-Specific T Cell Responses
in the Absence of LFA-1absence of different accessory molecules after anti-
genic stimulation was used to measure signal 2t. LFA-1±deficient mice have been reported to mount nor-
mal LCMV-specific CTL responses (Schmits et al., 1996).Using these principles, the present study analyzed
the contribution of LFA-1 and CD28 during T cell activa- To evaluate whether LCMV-infected APCs were able to
stimulate naive TCR-transgenic T cells in vitro in thetion. To study antigen-specific activation of naive T cells
in vitro and in vivo, transgenic mice expressing a TCR absence of LFA-1, spleen cells from LFA-1±deficient
mice were stimulated with LCMV-infected macrophages.specific for the glycoprotein of lymphocytic choriomen-
ingitis virus (LCMV) (Pircher et al., 1989) were crossed LFA-1±deficient T cells proliferated efficiently albeit
somewhat less compared with control T cells (Figurewith mice deficient for CD28 (TCR3CD282/2) (Shahi-
nian et al., 1993) or LFA-1 (TCR3LFA2/2) (Schmits et 2A). This indicated that sufficient LCMV peptide was
present on LCMV-infected macrophages to confer T cellal., 1996). The results show that CD28 is a costimulatory
molecule that delivers signal 2c by reducing the amount proliferation in the absence of LFA-1. To determine
whether LCMV infection could stimulate LFA-1±deficientof signal 1 necessary for T cell activation and is essential
for signal 2t. In contrast, LFA-1 does not deliver signal transgenic T cells in vivo, adoptive transfer experiments
were performed (Moskophidis et al., 1993; Zimmermann2c nor signal 2t but facilitates generation of signal 1 in
particular at low antigen concentrations by promoting et al., 1996). One million transgenic T cells were trans-
ferred into nonirradiated C57BL/6 recipient mice andadhesion of T cells to APCs. Thus, CD28 delivers signal
2c by modulating signal 1 and delivers signal 2t while subsequently infected with LCMV. One week later,
splenocytes were isolated and analyzed for the presenceLFA-1 assists T cell activation by facilitating the T cell±
APC interaction. of TCR transgenic T cells. Both LFA-1±deficient and
control T cells had dramatically expanded and repre-
sented the majority of CD81 T cells in recipient mice
Results (Figure 2B). In addition, lytic activity of transgenic T cells
was comparable on EL-4 cells pulsed with the peptide
Differential Affects of Ligand Quality versus MB6, which is recognized by transgenic T cells but not
Ligand Concentration on LFA-1± or by endogenous CTLs of the recipient (Bachmann et al.,
CD28-Mediated T Cell Activation 1997b; Figure 2C). Thus, LFA-1±deficient TCR-transgenic
To analyze the importance of LFA-1 and CD28 to induce T cells responded strongly to LCMV infection both in vitro
proliferation of naive T cells, spleen cells from TCR- and in vivo, since ligand densities achieved during LCMV
transgenic mice deficient for LFA-1 (TCR3LFA2/2), infection are sufficientlyhigh for LFA-1±independent T cell
CD28 (TCR3CD282/2), or control littermates (TCR) activation.
were stimulated in vitro with splenic APCs pulsed with
graded doses of peptide p33. Proliferation was as- In Vivo Activation of T Cells in the Absence
sessed 2 days later (Figure 1A). While TCR3CD282/2 of LFA-1 or CD28
T cellsproliferated similarly to control cells, TCR3LFA2/2 In vitro experiments performed thus far had suggested
that the absence of CD28 does not influence the amountT cells failed to proliferate at low peptide doses, and
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Figure 1. TCR3LFA2/2 T Cells Fail to Prolif-
erate at Low Ligand Density While TCR3
CD282/2 T Cells Fail to Proliferate after Stim-
ulation with a Low-Affinity Ligand
Spleen cells from control TCR, TCR3LFA2/2,
or TCR3CD282/2 mice were stimulated with
APCs pulsed with various concentrations of
peptide p33.
(A) Proliferation was assessed 48 hr later by
[3H]thymidine incorporation.
(B) Or the presence of lytic effector cells was
assessed 3 days later on p33-pulsed EL-4
cells.
(C) Proliferative responses of T cells from
TCR, TCR3LFA2/2, and TCR3CD282/2
mice were analyzed after stimulation with the
low-affinity ligand A4Y. One representative
experiment of five (A and B) or three (C) is
shown.
of ligand needed for T cell activation, while about 100 not alter TCR internalization. Interestingly, LFA-1±defi-
cient T cells failed to modulate TCR expression at lowtimes greater p33 concentrations were required for T
cell activation in the absence of LFA-1. To extend these peptide concentrations. This indicated that LFA-1 was
essential for a functional signal 1 at low ligand density. Inobservations in vivo, the mutant mice were injected with
various doses of p33. Twenty-four hours later, spleen contrast LFA-1 was dispensable for efficient TCR down-
regulation at high peptide concentrations. Absence ofcells were isolated and CD69 expression was assessed
on CD81 T cells expressing the transgenic TCR (Va2). CD28 had no influence on the kinetics of TCR down-
regulation. If assessed with APCs pulsed with a highAbout ten times more peptide was required for similar
CD69 expression levels in cells lacking LFA-1 (Figure concentration of p33, absence of LFA-1 also did not
alter the kinetics of TCR internalization (data not shown).3A). If CD69 expression was assessed in TCR3CD282/2
mice, it was also slightly reduced. Overall, the effects on
CD69 expression were limited. However, the induction of Absence of CD28 Does Not Interfere with TCR
lytic effector cells evaluated in the same experiment Down-Regulation after Stimulation
demonstrated that at least 1000-fold more peptide p33 with Low-Affinity Ligands
was required to induce CTL in TCR3LFA2/2 mice, while
TCR3CD282/2 T cells fail to proliferate after stimula-
T cells from TCR3CD282/2 mice responded normally
tion with the low affinity ligand A4Y (Figure 1B) (Bach-
(Figure 3B). This confirms earlier data that expression
mann et al., 1996). To assess whether A4Y failed to
of activation markers such as CD69 can be uncoupled
stimulate TCR internalization and hence signal 1 in the
from T cell proliferation and effector cell induction
absence of CD28, T cells from the different mouse
(Bachmann et al., 1996). strains were activated with A4Y. Interestingly, the pep-
tide A4Y-mediated TCR internalization in CD28-deficient
LFA-1 but Not CD28 Facilitates Generation T cells was as efficient as with control T cells (Figure
of Signal 1 5). This demonstrated that the failure of A4Y to induce
The in vitro and in vivo experiments suggested that proliferation of CD28-deficient T cells was not due to a
LFA-1 but not CD28 altered the peptide concentration failure to trigger TCR down-regulation. Although TCR
required for T cell activation. However, these studies down-regulation was markedly reduced in LFA-1±defi-
did not address whether LFA-1 directly altered TCR- cient T cells, it was nevertheless clearly observable at
mediated signals. Functionally triggered TCRs are inter- high A4Y concentrations (Figure 5) and sufficient to stim-
nalized shortly after stimulation (Meuer et al., 1984; Vali-
ulate T cell proliferation (Figure 1).
tutti et al., 1995b). TCR down-regulation therefore can
be used to assess the number of functionally triggered
LFA-1 Is Required for Ca21-Flux at LowTCRs and thus the amount of signal 1 (Viola and Lanza-
Ligand Densityvecchia, 1996; Bachmann et al., 1997a). To assess
LFA-1 was essential for induction of TCR down-regula-whether LFA-1 altered the intensity of signal 1, spleno-
tion at low ligand concentrations. Since TCR down-regu-cytes from TCR3LFA-12/2 or TCR3CD282/2 and
lation is an important parameter for T cell activation,control TCR mice were incubated with peptide-pulsed
one would predict that an absence of LFA-1 would inter-macrophages. Expression levels of TCRswere assessed
fere with early events of T cell activation, in particular5 hr later (Figure 4). As described previously, strong TCR
at low ligand densities. Therefore, we investigated thedown-regulation occurred on control T cells (Bachmann
importance of LFA-1 for the induction of Ca21-flux. Pep-et al., 1997a). The extent of down-regulation was largely
tide p33 induced long-lasting Ca21-flux in control TCR-independent of the peptide concentrations between
transgenic T cells at concentrations as low as 10210 M1026 and 1029 M; at 10210 M, down-regulation was less
(Figure 6A). In contrast, Ca21-flux was absent in TCR3pronounced and was not detectable at lower concentra-
LFA2/2 T cells at low peptide concentrations (Figuretions. Identical results were obtained with CD28-defi-
cient T cells, indicating that the absence of CD28 does 6B). Approximately 100 times more p33 was required
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Figure 3. In Vivo Activation of T Cells in the Absence of LFA-1 or
CD28
Control TCR, TCR3LFA2/2, and TCR3CD282/2 mice were immu-
nized with various doses of peptide p33.
(A) Expression of the activation marker CD69 was assessed 24 hr
later, and the mean fluorescence intensity is shown for CD81 T cells.
(B) Presence of effector cells was assessed 24 hr after injection of
10 mg (triangles), 1 mg (circles), 0.1 mg (squares), 0.01 mg (diamonds),
Figure 2. Functional LCMV-Specific T Cell Responses in the Ab- or no peptide p33 (crosses) on p33 pulsed target cells. Each line
sence of LFA-1 represents the mean of two mice. One representative experiment
(A) Spleen cells from controlTCR or TCR3LFA2/2 mice werestimu- of two is shown.
lated with LCMV-infected macrophages. Proliferation was assessed
48 hr later by [3H]thymidine incorporation.
(B) One million spleen cells from control TCR or TCR3LFA2/2 mice APCs during the Ca21 experiment was determined.
were adoptively transferred into normal, nonirradiated C57BL/6 Again about 100 times more peptide p33 was required
mice, which were subsequently immunized with LCMV (200 pfu).
in the absence of LFA-1 to induce an increase in TSeven days later, the presence of transgenic CD81 T cells express-
cell±APC complex formation (Figure 6C). This resulting Va2 was assessed in recipient mice by FCM analysis.
demonstrates that LFA-1 exerts its accessory function(C) Presence of TCR-transgeniceffector cells was assessed in recip-
ient mice by a 51Cr-release assay. Peptide MB6 (triangles), which is for T cell activation primarily by facilitating cell adhesion.
specifically recognized by TCR-transgenic T cells but not by endog-
enous T cells of recipient mice, or a control peptide (circles) was CD28 but Not LFA-1 Is Essential for Signal 2t
used to pulse the target cells. One representative experiment of two
The two-signal theory of T cell activation predicts thatis shown.
T cells receiving a functional signal 1 in the absence of
signal 2 undergo anergy. As shown here (Figure 7) and
previously in the LCMV model (KuÈ ndig et al., 1996),to induce Ca21-flux in TCR3LFA2/2 T cells, which is
consistent with the results of the TCR down-regulation CD28-deficient T cells stimulated in vivo with peptide
become anergic, confirming that CD28 is an importantassays (Figure 4). Thus, LFA-1±deficient T cells required
about 100 times more peptide for TCR down-regulation, mediator of the second signal (Harding et al., 1992; Lin-
sley and Ledbetter, 1993). To determine whether LFA-1Ca21-flux, and T cell proliferation. This finding suggests
that the LFA-1/I-CAM interaction is essential for the T plays a similar role, TCR transgenic mice deficient for
LFA-1 or CD28 were injected with peptide p33 (1 mg).cell APC interaction at low ligand densities and for the
generation of a functional signal 1, but absence of LFA-1 Three days later, spleen cells were isolated and stimu-
lated in vitro with peptide-pulsed APCs in the presencecan be compensated for by increasing the ligand density.
To assess whether LFA-1 may exert its effect by in- or absence of exogenous IL-2 (ConA supernatant). Pro-
liferation was assessed 2 days later (Figure 7). p33creasing T cell±APC adhesion at low peptide concentra-
tions, the percentage of T cells forming complexes with primed control and LFA-1±deficient T cells proliferated
Discrete Mechanisms to Augment T Cell Activation
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Figure 5. Absence of CD28 Does Not Alter TCR Down-Regulation
Mediated by a Weak Agonist
Spleen cells from control TCR, TCR3LFA2/2, or TCR3CD282/2
mice were stimulated with macrophages pulsed with various con-
centrations of peptide A4Y, and TCR expression was assessed 5
hr later for CD81 T cells. TCR expression is shown as percent of
control as a function of the peptide concentration used to pulse the
macrophages. One representative experiment of three is shown.
the natural peptide of LCMV presented on APCs, effi-
cient T cell proliferation and CTL-effector function could
be induced in vivo and in vitro. The extent of proliferation
Figure 4. Reduced Concentration-Dependent TCR Down-Regula- and the efficiency of target cell lysis by LFA-1±deficient
tion after Peptide Stimulation in the Absence of LFA-1 but Not CD28
T cells was similar to control cells. At lower ligand densi-
Spleen cells from control TCR, TCR3LFA2/2, or TCR3CD282/2 ties, however, LFA-1 proved pivotal. Under these condi-mice were stimulated with macrophages pulsed with various con-
tions, T cells failed to proliferate and differentiate tocentrations of peptide p33, and TCR expression was assessed 5 hr
effector cells in vitro in theabsence of LFA-1.Stimulationlater for CD81 T cells by FCM.
(A) Representative profiles are shown for the different T cells. with low affinity peptides yielded similar results. Thus,
(B) TCR expression is shown as percent of control as a function of LFA-1 shifted the dose response curve of T cells; LFA-1
peptide concentration used to pulse the macrophages. One repre- was essential at low ligand concentrations, but normal
sentative experiment of three is shown. T cell responses could be observed at high ligand con-
centrations both with high and low affinity ligands. This
finding differs from a recent report, where LFA-1 was
comparably to unprimed control T cells. In contrast, found to be crucial for the induction of T cell prolifera-
CD28-deficient T cells failed to proliferate in theabsence tion, independent of the ligand density (Cai et al., 1997).
of IL-2. Addition of IL-2, however, rescued proliferation Although there is not an obvious explanation for this
to control levels, characterizing the observed unrespon- discrepancy, the use of I-CAM±transfected insect cells
siveness as anergy (Figure 7). Thus, CD28, but not LFA-1, rather than macrophages for T cell stimulation in the
was crucial for a functional signal 2t. earlier study may be responsible for the difference. Dur-
ing physiological T cell activation, additional adhesion
Discussion molecules such as CD2 are present that may assist LFA-1
during the T cell±APC interaction (Davis and vander-
To dissect the underlying mechanisms that govern effi- Merve, 1996). These additional molecules were probably
cient T cell activation, we compared the roles of LFA-1 missing on the transfected insect cells, possibly ex-
and CD28 during T cell stimulation. Our results indicate plaining the absolute requirement for LFA-1 during T
that CD28 and LFA-1 exhibit different, nonoverlapping cell activation in this system.
roles for T cell activation. To analyze the role of LFA-1 during T cell activation
in more detail, TCR internalization and induction of Ca21-
flux was assessed after peptide specific stimulation. AtThe Role of LFA-1 for T Cell Activation:
Facilitation of Signal 1 high peptide concentrations, the extent and kinetics of
TCR internalization and increases in free intracellularIt has been suggested that the LFA-1/I-CAM interaction
is critical for full T cell activation (Davignon et al., 1981; Ca21 were not affected by the absence of LFA-1. In
contrast, at low ligand density, both functions wereSpringer et al., 1987; Seventer et al., 1990; Sligh et al.,
1993; Cai et al., 1996, 1997). This view is in contrast with strongly impaired, indicating that the TCR-mediated sig-
nal 1 is reduced at low ligand density in the absence ofthe finding that LFA-1±deficient mice mounted normal
LCMV-specific immune responses (Schmits et al., 1996). LFA-1. Together with our finding that LFA-1 is critical
for the formation of T cell±APC complexes at low peptideOur results offer an explanation for the discrepancy.
Using LCMV-infected APCs or high concentrations of densities (Figure 6), these results suggest that LFA-1
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Figure 6. LFA-1±Deficient T Cells Fail to In-
crease Intracellular Ca21 and to Form Com-
plexes with APCs Pulsed with Low Concen-
trations of p33
(A and B) Spleen cells from TCR-transgenic
control (A) or LFA-1±deficient (B) mice were
centrifuged with macrophages pulsed with
various concentrations of peptide p33. Three
minutes later, cells were resuspended and
free intracellular Ca21 was measured (by the
Indo-1 405/485 ratio) for the indicated time.
(C) The percentage of CD81 T cells forming
complexes with APCs was assessed during
the experimentshown in (A andB). One repre-
sentative experiment of two is shown.
facilitates generation of signal 1 by enhancing T cell± p33 stimulation were normal in the absence of CD28,
consistent with the observed normal T cell activation.APC adhesion. Thus, LFA-1 largely contributes to T cell
activation by physicochemical rather than biochemical Peptide A4Y induced a reduced, but nevertheless signif-
icant, TCR down-regulation on normal T cells. Althoughparameters.
A4Y failed to trigger T cell proliferation in the absence
of CD28, TCR down-regulation after stimulation withThe Role of CD28 for T Cell Activation:
Modulation of Signal 1 peptide A4Y was similar in the presence or absence
of CD28. Thus, CD28 does not directly alter signal 1.Induction of T cell proliferation after stimulation with p33
was only marginally affected by the absence of CD28. However, it apparently influences the number of TCRs
that need to be triggered for T cell activation: the re-However, unlike LFA-1±deficient T cells, the CD28-defi-
cient T cells failed to proliferate after stimulation with the duced number of triggered TCRs with the low-affinity
peptide A4Y induced T cell activation in the presence,low-affinity ligand A4Y regardless of the concentration.
Thus, the roles of LFA-1 and CD28 during T cell activa- but not in the absence, of CD28. These observations
using naive T cells are consistent with an earlier studytion are distinct. LFA-1 is essential for T cell activation
at low ligand densities, while the affinity of the peptide using T cell clones, where CD28 was found to influence
the minimal number of TCRs necessary for activation offor the TCR plays a minor role. In contrast, CD28 is
critical for T cell activation at low ligand affinity, indepen- the T cell clones (Viola and Lanzavecchia, 1996). Inter-
estingly, p33-induced T cell proliferation was indepen-dent of the ligand density. Thus, LFA-1 is critical for low
avidity T cell±APC interactions, while CD28 is pivotal for dent of CD28 also at low ligand concentrations. This
observation is explained by the finding that even verylow affinity TCR-MHC/peptide interactions.
Kinetics and the extent of TCR down-regulation after low concentrations of p33 induce massive TCR down-
regulation that is apparently sufficient for CD28-inde-
pendent T cell activation.
CD28 thus does not change the amount of signal 1
generated during the T cell±APC interaction but modu-
lates the amount of signal 1 required for T cell activation.
CD28 may therefore be considered a true costimulatory
molecule that delivers signal 2c by modulating signal 1.
CD28 but Not LFA-1 Is Critical for Signal 2t
According to the two-signal theory of T cell activation,
T cells receiving an antigen-specific signal 1 in the ab-
sence of the second signal are rendered unresponsive
(Lafferty and Woolnough, 1977; Cohn and Langman,
1990; Schwartz, 1990). It is important to distinguish this
type of signal from others influencing T cell activation.
If p33 was injected into TCR3CD282/2 mice, the spe-
cific T cells became functionally unresponsive within 3
days, confirming earlier observations (KuÈ ndig et al.,
Figure 7. Absence of LFA-1 Does Not Lead to T Cell Anergy In Vivo 1996). TCR3LFA2/2 T cells, however, were not aner-
Control TCR, TCR3LFA2/2, or TCR3CD282/2 mice were injected gized at this time point and responded comparably to
with the peptide p33 (1 mg). Three days later, spleen cells were T cells from uninjected TCR3LFA12/2 mice. This indi-
isolated and stimulated with p33-pulsed APCs in the presence or
cated that a functional signal 2t could be generated inabsence of IL-2. Proliferation was assessed 48 hr later. Proliferation
the absence of LFA-1 but not in the absence of CD28.is expressed as percent of proliferation of spleen cells from unin-
jected mice. One representative experiment of two is shown. It is important to point out that CD28 may not always
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Experimental Proceduresbe absolutely necessary for signal 2t. Immunization of
CD28-deficient mice with LCMV or vaccinia virus does
Mice and Virusesnot induce T cell unresponsiveness but leads to long-
Transgenic mice expressing a T cell receptor specific for peptide
term T cell memory (KuÈ ndig et al., 1996). Thus, during LCMV GP33-41 presented in association with H-2Db (Pircher et al.,
a viral infection but not following peptide injection, an 1989) and gene-targeted mice lacking expression of LFA-1 (Schmits
et al., 1996) and CD28 (Shahinian et al., 1993) have been describedalternative interaction may generate signal 2t and pre-
previously. The LCMV isolate WE was provided by Dr. R. M. Zinker-vent induction of long-lasting unresponsiveness. One
nagel, ZuÈ rich, Switzerland and grown on L cells at a low multiplicitypossibility for signal 2t replacement may be a sustained
of infection.signal 1 after viral infection (KuÈ ndig et al., 1996). In addi-
tion, induction of inflammatory cytokines probably also Peptides
plays a role. Peptides p33 (KAVYNFATM), A4Y (KAVANFATM), and MB6 (KAVVNI-
ATM) were generated at the Amgen Institute (Boulder, CO) by a
solid phase method using the Fmoc/tBu-based protocol on an ABI-
431 instrument. The crude product was purified by high performanceT Cell Activation as a Multistep Process
liquid chromatography (HPLC). p33 defines the major CTL epitopeT cell activation may be divided into at least three
on the LCMV GP in the H-2b haplotype (Pircher et al., 1990). Tophases. First, the T cells and APCs make contact. In a
prevent disulphide bonds, the C-terminal C has been replaced by
second phase, TCRs get triggered and are internalized. an M (Pircher et al., 1993).
In a third phase, which may overlap with the second
phase, T cells proliferate, differentiate to variouseffector Induction of LCMV-Specific Primary In Vitro
T Cell Responsescells, and/or are tolerized. Different accessory mole-
Spleen cells (1 3 105 cells/well) from naive mice expressing acules contribute to T cell activation during these three
transgenic receptor specific for LCMV GP (p33) were stimulated inphases. In the first phase, adhesion molecules such as
vitro with macrophages or splenic APCs (104/well or 5 3 104/well,
LFA-1 and CD2 are of critical importance, in particular respectively) pulsed with various amounts of peptides in 96-well
at low ligand concentrations. After the initial contact has plates. Proliferation was assessed 48 hr later by means of [3H]thymi-
been made, costimulatory molecules influence T cell dine incorporation. To assess induction of lytic effector cells, spleen
cells from TCR-transgenic mice (3 3 106/ml) were stimulated withactivation by delivering signal 2c. They may change the
peptide-pulsed macrophages (105 cells/well). Three days later,number of TCRs that have to be triggered for T cell
spleen cells were resuspended in 1/2 ml of medium per culture well,activation, as shown here for CD28. Other costimulatory
and serial 3-fold dilutions of effectors were performed (results are
molecules may alter the kinetics of TCR-triggering dur- shown for a 1/3 dilution) and tested in a conventional 51Cr release
ing the second phase. This is not the case for CD28 but assay using p33 pulsed (1025 M) EL-4 cells as target cells (Bach-
it is possible that such a role will be found for 41BB or mann, 1997).
yet unknown molecules. During the third phase, different
In Vivo Activation of T Cellsparameters will influence the outcome of T cell activa-
TCR-transgenic mice were injected intravenously with various dosestion. The total number of triggered TCRs will influence
of peptide p33. Twenty-four hours later, spleen cells were tested in
the types of effector functions induced, and the pres- 51Cr-release assays on p33-pulsed target cells. Cells were also
ence or absence of signal 2t will decide whether or stained for expression of CD8 (FITC, Cedarlane, Ontario, Canada),
not T cell unresponsiveness is induced. Thus, adhesion Va2 (PE, Pharmingen, San Diego, CA),and CD69 (Biotin, Pharmingen
followed by Streptavidin-RED670, GIBCO, BRL, Grand Island, NY)molecules are critical for the first phase, costimulatory
and analyzed by FCM.molecules may modulate the second phase, and mole-
cules delivering signal 2t are crucial for the third phase.
In Vivo Expansion and Effector Cell Induction
Spleen cells from TCR-transgenic LFA-1 or CD28±deficient and con-
trol mice (106 cells) were adoptively transferred into normal C57BL/
Conclusion 6-recipient mice. One hour later, mice were challenged with LCMV.
At the indicated time points, spleen cells were harvested and stained
for CD8 (PE, Pharmingen) and transgenic Va2 expression (FITC,T cell activation generally requires accompanying sig-
Pharmingen), and the presence of TCR-transgenic cells was as-nals in addition to the antigen-specific TCR-MHC/pep-
sessed by FCM analysis.tide interactions. Molecules that deliver these additional
To assess cytolytic effector function, spleen cells were tested
stimuli are generally termed costimulatory molecules in 51Cr-release assays using peptide-pulsed EL-4 target cells. To
and are often considered equal to signal 2 of the two- distinguish endogenous CTL activity of the C57BL/6 recipient mice
signal theory. This study demonstrates that this view is a from CTL activity of the transferred TCR-transgenic T cells, EL-4
cells pulsed with peptide MB6 were used as target cells. MB6 is onlymassive oversimplification and that different accessory
recognized by the TCR-transgenic T cells but not by the polyclonalmolecules alter T cell activation in distinct, nonoverlap-
C57BL/6 T cells (Bachmann et al., 1997b).ping ways. While the functional effect of the additional
stimuli may be similar, e.g., increased proliferation, the
Ca21-Flux
mechanism by which this effect is achieved is funda- Spleen cells were loaded with Indo-1 (10 mM) for 1 hr at 378C in
mentally different. The two molecules studied here, Iscove's modified Dulbecco's medium supplemented with 2% FCS.
Cells were stained for CD4 and B220 expression, and Indo-LFA-1 and CD28, have three distinct effects on T cell
11CD42B2202 cells exhibiting a large forward scatter correspondingactivation. LFA-1 facilitates generation of signal 1, in
to T cell±APC duplexes, were analyzed with a FACS Vantage (Bectonparticular at low ligand densities, but does not deliver
Dickinson) and Cell Quest-Software, using a ion laser (Innova Enter-signal 2c nor signal 2t. In contrast, CD28 modulates
prise, Coherent, Santa Clara, CA) optimized for UV argon ions, set
signal 1 by reducing the minimal number of TCRs that for 355-nm excitation at a power setting of 50 mV. For stimulation
have to be triggered for T cell activation and is essential of T cells, peritoneal macrophageswere pulsed with various concen-
trations of p33 for 1 hr. Macrophages (4 3 106/ml) were mixed withfor a functional signal 2t.
Immunity
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spleen cells (1 3 107 cell/ml) at 48C, centrifuged, and warmed up to Dustin, M.L., and Springer, T.A. (1989). T-cell receptor cross-linking
transiently stimulates adhesiveness through LFA-1. Nature 341,378C for 3 minutes. Cells were gently resuspended and immediately
analyzed. Results are expressed as mean channel of 405/485 nm 619±624.
(violet/blue) ratio less the mean channel of violet/blue ratio of T cells Finck, B.K., Linsley, P.S., and Wofsy, D. (1994). Treatment of murine
stimulated with unpulsed APCs (Viola and Lanzavecchia, 1996). To lupus with CTLA4-Ig. Science 265, 1225±1227.
determine the number of T cells forming complexes with APCs, the
Goodwin, R.G., Din, W.S., Davis-Smith, T., Anderson, D.M., Gimpel,frequency of Indo-11CD42B2202 cells with a large forward scatter
S.D., Sato, T.A., Maliszewski, C.R., Brannan, C.I., Copeland, N.G.,(corresponding to the forward scatter of the T cells conjugated to
Jenkins, N.A., Farrah, T., Armitage, R.J., Fanslow, W.C., and Smith,APCs) was determined (Valitutti et al., 1995a).
C.A. (1993). Molecular cloning of a ligand for the inducible gene
4-1BB: a member of an emerging family of cytokines with homology
Induction of TCR Down-Regulation
to the tumor necrosis factor. Eur. J. Immunol. 23, 2631±2638.
Spleen cells from TCR-transgenic mice (105/well) were mixed with
Harding, F.A., McArthur, J.G., Gross, J.A., Raulet, D.H., and Allison,peptide-pulsed macrophages (2 3 105/well), centrifuged, and incu-
J.P. (1992). CD28-mediated signalling co-stimulates murine T cellsbated at 378C (5% CO2) in IMDM supplemented with 10% FCS in
and prevents induction of anergy in T-cell clones. Nature 356,round bottom 96-well plates. At the indicated time points, cells were
607±609.harvested and stained for CD8 (PE, Pharmingen) and Va2 (FITC,
Pharmingen), and Va2 expression is shown for CD81 T cells. KuÈndig, T.M., Shahinian, A., Kawai, K., MittruÈ cker, H.-W., Sebzda,
E., Bachmann, M.F., Mak, T.W., and Ohashi, P.S. (1996). Duration
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